Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization: Case report and literature review

Surgical Neurology

Volumn 62, Issue 4, 2004, Pages 304-311

  Bendok, Bernard R ^a,b   Padalino, David J ^a   Levy, Elad I ^a   Qureshi, Adnan I ^a,c,d   Guterman, Lee R ^a   Hopkins, L Nelson ^a,e  

^a UNIVERSITY AT BUFFALO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ALBANY MEDICAL CENTER   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

Abciximab; aneurysm; coils; thrombus

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ANGIOGRAPHY; ARTIFICIAL EMBOLISM; BLOOD CLOT LYSIS; CASE REPORT; HUMAN; INTRACRANIAL ANEURYSM; MALE; NEUROLOGIC DISEASE; POSTERIOR CEREBRAL ARTERY; REVIEW; THROMBOGENESIS; THROMBOSIS; THROMBUS;

EID: 4644329405     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2003.10.045     Document Type: Article

References (32)

1. Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke. 31:2000;601-609
2. Akkerhuis K.M., Deckers J.W., Lincoff A.M., et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA. 286:2001;78-82
3. Alexander M.J., Duckwiler G.R., Gobin Y.P., Vinuela F. Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab technical case report. Neurosurgery. 50:2002;899-902
4. Berkompas D.C. Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis. Cathet Cardiovasc Diagn. 45:1998;272-274
5. Boulos A.S., Bendok B.R., Levy E.I., et al. Endovascular aneurysm treatment a proven therapy. Neurol Res. 24:(Suppl 1):2002;S71-S79
6. CAPTURE Study Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina the CAPTURE Study. Lancet. 349:1997;1429-1435
7. Cloft H.J., Samuels O.B., Tong F.C., Dion J.E. Use of abciximab for mediation of thromboembolic complications of endovascular therapy. AJNR Am J Neuroradiol. 22:2001;1764-1777
8. Cronqvist M., Pierot L., Boulin A., Cognard C., Castaings L., Moret J. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm a comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol. 19:1998;157-165
9. Derdeyn C.P., Cross D.T. 3rd, Moran C.J., et al. Postprocedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. J Neurosurg. 96:2002;837-843
10. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961
11. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696
12. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 282:1999;2003-2011
13. Henry P., Boughalem K., Rinaldi J.P., et al. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation. Cathet Cardiovasc Diagn. 43:1998;105-107
14. Hofmann R., Kerschner K., Steinwender C., Kypta A., Bibl D., Leisch F. Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting a randomized study. Stroke. 33:2002;725-727
15. Kapadia S.R., Bajzer C.T., Ziada K.M., et al. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting a safe and effective adjunctive therapy. Stroke. 32:2001;2328-2332
16. Koebbe C., Horowitz M., Levy E., Dutton K., Jungries C., Purdy P. Intraarterial thrombolysis for thromboemboli associated with endovascular aneurysm coiling. AJNR Am J Neuroradiol. 8:2002;151-158
17. Kwon O.K., Lee K.J., Han M.H., Oh C.W., Han D.H., Koh Y.C. Intraarterially administered abciximab as an adjuvant thrombolytic therapy report of three cases. AJNR Am J Neuroradiol. 23:2002;447-451
18. Lempert T.E., Malek A.M., Halbach V.V., Phatouros C.C., Dowd C.F., Higashida R.T. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization. Stroke. 30:1999;693-695
19. Morrish W., Grahovac S., Douen A., et al. Intracranial hemorrhage after stenting and angioplasty of extracranial carotid stenosis. AJNR Am J Neuroradiol. 21:2000;1911-1916
20. Ng P.P., Phatouros C.C., Khangure M.S. Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol. 22:2001;1761-1763
21. Pelz D.M., Lownie S.P., Fox A.J. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol. 19:1998;1541-1547
22. Qureshi A.I., Luft A.R., Sharma M., Guterman L.R., Hopkins L.N. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures Part I-Pathophysiological and pharmacological features. Neurosurgery. 46:2000;1344-1359
23. Qureshi A.I., Luft A.R., Sharma M., Guterman L.R., Hopkins L.N. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures part II - Clinical aspects and recommendations. Neurosurgery. 46:2000;1360-1376
24. Qureshi A.I., Saad M., Zaidat O.O., et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 33:2002;1916-1919
25. Qureshi A.I., Siddiqui A.M., Suri M.F., et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke a prospective study. Neurosurgery. 51:2002;1319-1329
26. Qureshi A.I., Suri M.F., Ali Z., et al. Carotid angioplasty and stent placement a prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 50:2002;466-475
27. Qureshi A.I., Suri M.F., Khan J., Fessler R.D., Guterman L.R., Hopkins L.N. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty preliminary experience. Neurosurgery. 46:2000;1316-1325
28. Salzman E.W., Rosenberg R.D., Smith M.H., Lindon J.N., Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest. 65:1980;64-73
29. Vorchheimer D.A., Badimon J.J., Fuster V. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA. 281:1999;1407-1414
30. Wallace R.C., Furlan A.J., Moliterno D.J., Stevens G.H., Masaryk T.J., Perl J. 2nd. Basilar artery rethrombosis successful treatment with platelet glycoproteins IIB/IIIA receptor inhibitor. AJNR Am J Neuroradiol. 18:1997;1257-1260
31. Weitz J.I., Hudoba M., Massel D., Maraganore J., Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest. 86:1990;385-391
32. Workman M.J., Cloft H.J., Tong F.C., et al. Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol. 23:2002;1568-1576